Genome-wide association studies in type 2 diabetes

Current Diabetes Reports

Volumn 9, Issue 2, 2009, Pages 164-171

  McCarthy, Mark I ^a   Zeggini, Eleftheria ^b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; HEPATOCYTE NUCLEAR FACTOR 1BETA; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; NOTCH2 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM CHANNEL KCNQ1; TRANSCRIPTION FACTOR 7 LIKE 2;

CLINICAL ASSESSMENT; GENE FREQUENCY; GENE LOCUS; GENE NUMBER; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PATHOGENESIS; REVIEW; RISK ASSESSMENT;

DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; META-ANALYSIS AS TOPIC;

EID: 63349087565     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-009-0027-4     Document Type: Review

References (53)

1. Köbberling J, Tillil H: Empirical risk figures for first degree relatives of non-insulin-dependent diabetics. In The Genetics of Diabetes Mellitus. Edited by Köbberling J, Tattersall R. London: Academic Press; 1982:201-209.
2. McCarthy MI: Growing evidence for diabetes susceptibility genes from genome scan data. Curr Diab Rep 2003, 3:159-167.
3. Guan W, Pluzhnikov A, Cox NJ, Boehnke M; International Type 2 Diabetes Linkage Analysis Consortium: Meta-analysis of 23 type 2 diabetes linkage studies from the international type 2 diabetes linkage analysis consortium. Hum Hered 2008, 66:35-49.
4. International HapMap Consortium: A haplotype map of the human genome. Nature 2005, 437:1299-1320.
5. Frayling TM, Timpson NJ, Weedon MN, et al.: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
6. Altshuler D, Hirschhorn JN, Klannemark M, et al.: The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000, 26:76-80.
7. Gloyn AL, Weedon MN, Owen KR, et al.: Large scale association studies of variants in genes encoding the pancreatic beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with increased risk of type 2 Diabetes. Diabetes 2003, 52:568-572.
8. Sandhu MS, Weedon MN, Fawcett KA, et al.: Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 2007, 39:951-953.
9. Winckler W, Weedon MN, Graham RR, et al.: Evaluation of common variants in the six known MODY genes for association with type 2 Diabetes. Diabetes 2007, 56:685-693.
10. Gudmundsson J, Sulem P, Steinthorsdottir V, et al.: Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007, 39:977-983.
11. Grant SF, Thorleifsson G, Reynisdottir I, et al.: Variant of transcription factor 7-like 2 (TFC7L2) gene confers risk of type 2 diabetes. Nat Genet 2006, 38:320-323.
12. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316:1331-1336.
13. Scott LJ, Mohlke KL, Bonnycastle LL, et al.: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316:1341-1345.
14. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
15. Zeggini E, Weedon MN, Lindgren CM, et al.: Replication of genome-wide association signals in U.K. samples reveals risk loci for type 2 diabetes. Science 2007, 316:1336-1341.
16. Sladek R, Rocheleau G, Rung J, et al.: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445:828-830.
17. Salonen JT, Uimari P, Aalto JM, et al.: Type 2 diabetes whole-genome association study in four populations: The DiaGen consortium. Am J Hum Genet 2007, 81:338-345.
18. Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al.: A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat Genet 2007, 39:770-775.
19. Unoki H, Takahashi A, Kawaguchi T, et al.: SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 2008, 40:1098-1102.
20. Zeggini E, Scott LJ, Saxena R, et al.: Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 2008, 40:638-645.
21. Prokopenko I, Langenberg C, Florez JC, et al.: Variants in the melatonin receptor 1B gene (MTNR1B) influence fasting glucose levels. Nat Genet 2009, 41:77-81.
22. Lyssenko V, Nagorny CL, Erdos MR, et al.: Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009, 41:82-88.
23. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proenca C, et al.: A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet 2009, 41:89-94.
24. Yasuda K, Miyake K, Horikawa Y, et al.: Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet 2008, 40:1092-1097.
25. Marchini J, Howie B, Myers S, et al.: A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 2007, 39:906-913.
26. Fan JB, Chee MS, Gunderson KL: Highly parallel genomic assays. Nat Rev Genet 2006, 7:632-644.
27. Zeggini E, Rayner W, Morris AP, et al.: HapMap sample size and tagging SNP performance: An evaluation in largescale empirical and simulated data sets. Nat Genet 2005, 37:1320-1322.
28. McCarroll SA, Huett A, Kuballa P, et al.: Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 2008 Aug 24 (Epub ahead of print).
29. Frayling TM: Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 2007, 8:657-662.
30. McCarthy MI, Abecasis GR, Cardon LR, et al.: Genome wide association studies for complex traits: Consensus, uncertainty and challenges. Nat Rev Genet 2008, 9:356-369.
31. Lohmueller KE, Pearce CL, Pike M, et al.: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003, 33:177-182.
32. Dabelea D, Pettitt DJ: Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J Pediatr Endocrinol Metab 2001, 14:1085-1091.
33. McCarthy MI: Casting a wider net for diabetes-susceptibility genes. Nat Genet 2008, 40:1039-1040.
34. McCarroll SA, Kuruvilla FG, Korn JM, et al.: Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat Genet 2008, 40:1166-1174.
35. Hill WG, Goddard ME, Visscher PM: Data and theory point to mainly additive genetic variance for complex traits. PLoS Genet 2008, 4:e1000008.
36. Smyth DJ, Cooper JD, Howson JM, et al.: PTPN22 Trp620 explains the association of chromosome 1p13 with type 1 diabetes and shows a statistical interaction with HLA class II genotypes. Diabetes 2008, 57:1730-1737.
37. Grarup N, Rose CS, Andersson EA, et al.: Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects. Diabetes 2007, 56:3105-3111.
38. Pascoe L, Tura A, Patel SK, et al.: Common variants of the novel type 2 diabetes genes, CDKAL1 and HHEX/IDE, are associated with decreased pancreatic beta-cell function. Diabetes 2007, 56:3101-3104.
39. Staiger H, Machicao F, Stefan N, et al.: Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One 2007, 9:e832.
40. Staiger H, Stancáková A, Zilinskaite J, et al.: A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations. Diabetes 2008, 57:514-517.
41. Freathy RM, Timpson NJ, Lawlor DA, et al.: Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected, given its effect on BMI. Diabetes 2008, 57:1419-1426.
42. Leahy JL: Mary, Mary, quite contrary, how do your beta-cells fail? Diabetes 2008, 57:2563-2564.
43. Lyssenko V, Lupi R, Marchetti P, et al.: Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 2007, 117:2155-2163.
44. Chimienti F, Devergnas S, Pattou F, et al.: In vivo expression and functional characterization of the zinc transporter ZnT8 in glucose-induced insulin secretion. J Cell Sci 2006, 119:4199-4206.
45. Krishnamurthy J, Ramsey MR, Ligon KL, et al.: P16INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006, 443:453-457.
46. Barrett JC, Hansoul S, Nicolae DL, et al.: Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40:955-962.
47. Thomas G, Jacobs KB, Yeager M, et al.: Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008, 40:310-315.
48. Finkel T, Serrano M, Blasco MA: The common biology of cancer and ageing. Nature 2007, 448:767-776.
49. Kasper JS, Giovannucci E: A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:2056-2062.
50. Lango H; UK Type 2 Diabetes Genetics Consortium, Palmer CN, et al.: Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 2008, 57:3129-3135.
51. Gloyn AL, Pearson ER, Antcliff JF, et al.: Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004, 350:1838-1849.
52. Pearson ER, Flechtner I, Njølstad PR, et al.: Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006, 355:467-477.
53. Pearson ER, Donnelly LA, Kimber C, et al.: Variation in TCF7L2 influences therapeutic response to sulfonylureas: A GoDARTs study. Diabetes 2007, 56:2178-2182.